we conclude that inhibition of intestinal alpha-glucosidases by bay-m-1099 in iddm reduces meal insulin requirements by at least 20 % and that such an agent could be useful in the management of diabetes mellitus by reducing hyperinsulinemia .
C0011854
iddm
C0021641
insulin